265 related articles for article (PubMed ID: 33444637)
1. Kappa opioid receptor activation in the amygdala disinhibits CRF neurons to generate pain-like behaviors.
Hein M; Ji G; Tidwell D; D'Souza P; Kiritoshi T; Yakhnitsa V; Navratilova E; Porreca F; Neugebauer V
Neuropharmacology; 2021 Mar; 185():108456. PubMed ID: 33444637
[TBL] [Abstract][Full Text] [Related]
2. Kappa opioid receptors in the central amygdala modulate spinal nociceptive processing through an action on amygdala CRF neurons.
Ji G; Neugebauer V
Mol Brain; 2020 Sep; 13(1):128. PubMed ID: 32948219
[TBL] [Abstract][Full Text] [Related]
3. Kappa Opioid Receptor Blockade in the Amygdala Mitigates Pain Like-Behaviors by Inhibiting Corticotropin Releasing Factor Neurons in a Rat Model of Functional Pain.
Yakhnitsa V; Ji G; Hein M; Presto P; Griffin Z; Ponomareva O; Navratilova E; Porreca F; Neugebauer V
Front Pharmacol; 2022; 13():903978. PubMed ID: 35694266
[TBL] [Abstract][Full Text] [Related]
4. Non-pain-related CRF1 activation in the amygdala facilitates synaptic transmission and pain responses.
Ji G; Fu Y; Adwanikar H; Neugebauer V
Mol Pain; 2013 Feb; 9():2. PubMed ID: 23410057
[TBL] [Abstract][Full Text] [Related]
5. CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior.
Bruchas MR; Land BB; Lemos JC; Chavkin C
PLoS One; 2009 Dec; 4(12):e8528. PubMed ID: 20052275
[TBL] [Abstract][Full Text] [Related]
6. Optogenetic Manipulations of Amygdala Neurons Modulate Spinal Nociceptive Processing and Behavior Under Normal Conditions and in an Arthritis Pain Model.
Mazzitelli M; Marshall K; Pham A; Ji G; Neugebauer V
Front Pharmacol; 2021; 12():668337. PubMed ID: 34113253
[TBL] [Abstract][Full Text] [Related]
7. Kappa opioid signaling in the central nucleus of the amygdala promotes disinhibition and aversiveness of chronic neuropathic pain.
Navratilova E; Ji G; Phelps C; Qu C; Hein M; Yakhnitsa V; Neugebauer V; Porreca F
Pain; 2019 Apr; 160(4):824-832. PubMed ID: 30681985
[TBL] [Abstract][Full Text] [Related]
8. 5-HT
Ji G; Zhang W; Mahimainathan L; Narasimhan M; Kiritoshi T; Fan X; Wang J; Green TA; Neugebauer V
J Neurosci; 2017 Feb; 37(6):1378-1393. PubMed ID: 28011743
[TBL] [Abstract][Full Text] [Related]
9. Kappa opioid receptor activation decreases inhibitory transmission and antagonizes alcohol effects in rat central amygdala.
Gilpin NW; Roberto M; Koob GF; Schweitzer P
Neuropharmacology; 2014 Feb; 77():294-302. PubMed ID: 24157490
[TBL] [Abstract][Full Text] [Related]
10. Optogenetic manipulations of CeA-CRF neurons modulate pain- and anxiety-like behaviors in neuropathic pain and control rats.
Mazzitelli M; Yakhnitsa V; Neugebauer B; Neugebauer V
Neuropharmacology; 2022 Jun; 210():109031. PubMed ID: 35304173
[TBL] [Abstract][Full Text] [Related]
11. Role of corticotropin-releasing factor and its receptor in nociceptive modulation in the central nucleus of amygdala in rats.
Cui XY; Lundeberg T; Yu LC
Brain Res; 2004 Jan; 995(1):23-8. PubMed ID: 14644467
[TBL] [Abstract][Full Text] [Related]
12. Interaction of CRF and kappa opioid systems on GABAergic neurotransmission in the mouse central amygdala.
Kang-Park M; Kieffer BL; Roberts AJ; Siggins GR; Moore SD
J Pharmacol Exp Ther; 2015 Nov; 355(2):206-11. PubMed ID: 26350161
[TBL] [Abstract][Full Text] [Related]
13. Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior.
Fu Y; Neugebauer V
J Neurosci; 2008 Apr; 28(15):3861-76. PubMed ID: 18400885
[TBL] [Abstract][Full Text] [Related]
14. Localization of the delta opioid receptor and corticotropin-releasing factor in the amygdalar complex: role in anxiety.
Reyes BAS; Kravets JL; Connelly KL; Unterwald EM; Van Bockstaele EJ
Brain Struct Funct; 2017 Mar; 222(2):1007-1026. PubMed ID: 27376372
[TBL] [Abstract][Full Text] [Related]
15. Presynaptic CRF1 receptors mediate the ethanol enhancement of GABAergic transmission in the mouse central amygdala.
Nie Z; Zorrilla EP; Madamba SG; Rice KC; Roberto M; Siggins GR
ScientificWorldJournal; 2009 Jan; 9():68-85. PubMed ID: 19151899
[TBL] [Abstract][Full Text] [Related]
16. Contribution of Corticotropin-Releasing Factor Receptor 1 (CRF1) to Serotonin Receptor 5-HT
Ji G; Neugebauer V
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31489921
[TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species mediate visceral pain-related amygdala plasticity and behaviors.
Ji G; Li Z; Neugebauer V
Pain; 2015 May; 156(5):825-836. PubMed ID: 25734993
[TBL] [Abstract][Full Text] [Related]
18. Effects of voluntary alcohol drinking on corticotropin-releasing factor and preprodynorphin mRNA levels in the central amygdala of Sardinian alcohol-preferring rats.
Zhou Y; Colombo G; Gessa GL; Kreek MJ
Neurosci Lett; 2013 Oct; 554():110-4. PubMed ID: 24021806
[TBL] [Abstract][Full Text] [Related]
19. Corticotropin-releasing factor in the mouse central nucleus of the amygdala: ultrastructural distribution in NMDA-NR1 receptor subunit expressing neurons as well as projection neurons to the bed nucleus of the stria terminalis.
Beckerman MA; Van Kempen TA; Justice NJ; Milner TA; Glass MJ
Exp Neurol; 2013 Jan; 239():120-32. PubMed ID: 23063907
[TBL] [Abstract][Full Text] [Related]
20. A Corticotropin Releasing Factor Network in the Extended Amygdala for Anxiety.
Pomrenze MB; Tovar-Diaz J; Blasio A; Maiya R; Giovanetti SM; Lei K; Morikawa H; Hopf FW; Messing RO
J Neurosci; 2019 Feb; 39(6):1030-1043. PubMed ID: 30530860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
